The antibacterial properties of branched peptides based on poly(l-arginine): In vitro antibacterial evaluation and molecular dynamic simulations.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 08 12 2023
revised: 27 01 2024
accepted: 07 02 2024
medline: 18 3 2024
pubmed: 23 2 2024
entrez: 22 2 2024
Statut: ppublish

Résumé

The emergence of bacterial strains resistant to antibiotics is a major issue in the medical field. Antimicrobial peptides are widely studied as they do not generate as much resistant bacterial strains as conventional antibiotics and present a broad range of activity. Among them, the homopolypeptide poly(l-arginine) presents promising antibacterial properties, especially in the perspective of its use in biomaterials. Linear poly(l-arginine) has been extensively studied but the impact of its 3D structure remains unknown. In this study, the antibacterial properties of newly synthesized branched poly(l-arginine) peptides, belonging to the family of multiple antigenic peptides, are evaluated. First, in vitro activities of the peptides shows that branched poly(l-arginine) is more efficient than linear poly(l-arginine) containing the same number of arginine residues. Surprisingly, peptides with more arms and more residues are not the most effective. To better understand these unexpected results, interactions between these peptides and the membranes of Gram positive and Gram negative bacteria are simulated thanks to molecular dynamic. It is observed that the bacterial membrane is more distorted by the branched structure than by the linear one and by peptides containing smaller arms. This mechanism of action is in full agreement with in vitro results and suggest that our simulations form a robust model to evaluate peptide efficiency towards pathogenic bacteria.

Identifiants

pubmed: 38387338
pii: S0223-5234(24)00104-1
doi: 10.1016/j.ejmech.2024.116224
pii:
doi:

Substances chimiques

polyarginine 25212-18-4
Anti-Bacterial Agents 0
Antimicrobial Cationic Peptides 0
Arginine 94ZLA3W45F
Peptides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116224

Informations de copyright

Copyright © 2024. Published by Elsevier Masson SAS.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Lavalle reports financial support was provided by Région Grand Est. Vrana reports was provided by European Council. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Lebaudy Eloïse (L)

Inserm UMR_S 1121, EMR 7003 CNRS, Biomaterials and Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, F67000, Strasbourg, France; Université de Strasbourg, Faculté de Chirurgie Dentaire, Strasbourg, France.

Lauriane Petit (L)

Inserm UMR_S 1121, EMR 7003 CNRS, Biomaterials and Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, F67000, Strasbourg, France; Université de Strasbourg, Faculté de Chirurgie Dentaire, Strasbourg, France; SPARTHA Medical, Centre de Recherche en Biomédecine de Strasbourg, Strasbourg, France.

Yves Nominé (Y)

Institut de génétique et de biologie moléculaire et cellulaire, IGBMC, Illkirch, France.

Béatrice Heurtault (B)

Université de Strasbourg, Centre national de la recherche scientifique (CNRS), Laboratoire de Conception et Application de Molécules Bioactives UMR 7199, Faculté de Pharmacie, Illkirch, France.

Inès Ben Hadj Kaddour (I)

Inserm UMR_S 1121, EMR 7003 CNRS, Biomaterials and Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, F67000, Strasbourg, France; Université de Strasbourg, Faculté de Chirurgie Dentaire, Strasbourg, France; SPARTHA Medical, Centre de Recherche en Biomédecine de Strasbourg, Strasbourg, France.

Bernard Senger (B)

Inserm UMR_S 1121, EMR 7003 CNRS, Biomaterials and Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, F67000, Strasbourg, France; Université de Strasbourg, Faculté de Chirurgie Dentaire, Strasbourg, France.

Jennifer Rodon Fores (J)

Inserm UMR_S 1121, EMR 7003 CNRS, Biomaterials and Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, F67000, Strasbourg, France; Université de Strasbourg, Faculté de Chirurgie Dentaire, Strasbourg, France.

Nihal Engin Vrana (NE)

Université de Strasbourg, Faculté de Chirurgie Dentaire, Strasbourg, France; SPARTHA Medical, Centre de Recherche en Biomédecine de Strasbourg, Strasbourg, France.

Florent Barbault (F)

Université Paris Cité, CNRS, ITODYS, F75013, Paris, France.

Philippe Lavalle (P)

Inserm UMR_S 1121, EMR 7003 CNRS, Biomaterials and Bioengineering, Centre de Recherche en Biomédecine de Strasbourg, F67000, Strasbourg, France; Université de Strasbourg, Faculté de Chirurgie Dentaire, Strasbourg, France; SPARTHA Medical, Centre de Recherche en Biomédecine de Strasbourg, Strasbourg, France. Electronic address: philippe.lavalle@inserm.fr.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Populus Soil Microbiology Soil Microbiota Fungi

Classifications MeSH